To mechanistically determine the role of CD62L in NASH development and subsequent progression, we fed 12-week-old WT and CD62L−/− mice with steatosis and steatohepatitis inducing diets: MCD for 4 weeks and HFD for 24 weeks. This evidence concerns the gene SELL and metabolic dysfunction-associated steatohepatitis.